NKGen Biotech, Inc. Quarterly Cost of Revenue in USD from Q3 2022 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
NKGen Biotech, Inc. annual/quarterly Cost of Revenue history and growth rate from Q3 2022 to Q3 2023.
  • NKGen Biotech, Inc. Cost of Revenue for the quarter ending September 30, 2023 was $0.000.
  • NKGen Biotech, Inc. annual Cost of Revenue for 2023 was $0.000, a 100% decline from 2022.
Cost of Revenue, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $0 $0 Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q3 2022 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.